|
|
News Breaks
|
February 1, 2012
|
| 06:31 EDT |  | MNOV |
| theflyonthewall.com: | MedicNova receives notice of patent allowance for a method of treating MS | | MediciNova Inc, a biopharmaceutical company traded on the NASDAQ Global Market and the Jasdaq Market of the Osaka Securities Exchange (4875), announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for a pending patent application, which covers the use of ibudilast for the treatment of progressive forms of multiple sclerosis. Ibudilast (MN-166), is the company's lead drug development candidate for certain neurological conditions, including progressive multiple sclerosis, neuropathic pain, and drug addiction. :theflyonthewall.com |
|
|
News For MNOV From The Last 14 Days Check below for free stories on MNOV the last two weeks.
There are 2 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing. |
|
May 23, 2012
|
| 16:03 EDT | | MNOV |
| | 16:01 EDT | | MNOV |
|
|
|
|
|
Subscribe for More Information